Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Allysine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001680 AN002738 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine Abundance
ST003085 AN005044 Metabolome changes in embryonic CSF (Part 7) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) Blood Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) CSF Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST003088 AN005050 Metabolome changes in embryonic CSF (Part 10) Liver Mouse Autism Boston Children's Hospital, Harvard Medical School a.u.
ST003028 AN004964 Chronic stress dampens Lactobacillus johnsonii-mediated tumor suppression to enhance colorectal cancer progression Colon Mouse Cancer China Pharmaceutical University count per second (cps)
ST002010 AN003276 Chemoresistant Ovarian Cancer Global Metabolomics Cultured cells Human Cancer The University of South Australia Intensity
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky normalized corrected peak area
ST000040 AN000060 Heatshock response of C. elegans using IROA (I) Worms C. elegans University of Florida Peak area
ST000040 AN000061 Heatshock response of C. elegans using IROA (I) Worms C. elegans University of Florida Peak area
ST000142 AN000225 H1299 13C-labeled Cell Study Lung Human Cancer University of Kentucky Peak area
ST002787 AN004535 Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome Feces Human Cancer Wuhan University of Science and Technology Peak area
ST002066 AN003365 Glutaminase inhibition impairs CD8 T cell activation in STK11/Lkb1 deficient lung cancer Lung Mouse Cancer The Walter and Eliza Hall Institute of Medical Research peak height
ST002104 AN003439 Chemoresistant Cancer Cell Lines are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations Cultured cells Human Cancer Future Industries Institute peak height
ST002698 AN004372 Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites Infected Red Blood Cells Plasmodium berghei Malaria Peter Doherty Institute for Infection and Immunity peak height
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University peak height
ST003036 AN004977 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences peak height
ST003144 AN005159 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University peak height
ST003521 AN005782 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University peak height
ST003521 AN005783 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University peak height
ST000403 AN000643 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000539 AN000819 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000549 AN000838 Investigating large scale metabolomics in mice serum lacking insulin receptors and IGF-1 receptors Blood Mouse Diabetes Mayo Clinic Peak intensity
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
  logo